| Literature DB >> 34698087 |
Yanhong Li1, Jie Wang1, Mauricio A Elzo2, Huimei Fan1, Kun Du1, Siqi Xia1, Jiahao Shao1, Tianfu Lai1, Shenqiang Hu1, Xianbo Jia1, Songjia Lai1.
Abstract
DNA methylation and the alternative splicing of precursor messenger RNAs (pre-mRNAs) are two important genetic modification mechanisms. However, both are currently uncharacterized in the muscle metabolism of rabbits. Thus, we constructed the Tianfu black rabbit obesity model (obese rabbits fed with a 10% high-fat diet and control rabbits from 35 days to 70 days) and collected the skeletal muscle samples from the two groups for Genome methylation sequencing and RNA sequencing. DNA methylation data showed that the promoter regions of 599 genes and gene body region of 2522 genes had significantly differential methylation rates between the two groups, of which 288 genes had differential methylation rates in promoter and gene body regions. Analysis of alternative splicing showed 555 genes involved in exon skipping (ES) patterns, and 15 genes existed in differential methylation regions. Network analysis showed that 20 hub genes were associated with ubiquitinated protein degradation, muscle development pathways, and skeletal muscle energy metabolism. Our findings suggest that the two types of genetic modification have potential regulatory effects on skeletal muscle development and provide a basis for further mechanistic studies in the rabbit.Entities:
Keywords: DNA methylation; alternative splicing; metabolic network; rabbit; skeletal muscle
Mesh:
Substances:
Year: 2021 PMID: 34698087 PMCID: PMC8929151 DOI: 10.3390/cimb43030110
Source DB: PubMed Journal: Curr Issues Mol Biol ISSN: 1467-3037 Impact factor: 2.976
Whole-methylome bisulfite sequencing data from skeletal muscle in CON−G and HFD−G 1.
| Group | Clean | Clean | Mapped | Mapping | Unique Mapped | Unique Mapping | Bisulfite Conversion |
|---|---|---|---|---|---|---|---|
| CON−G | 606,327,246 | 90,949,086,900 | 515,160,587 | 84.96 | 486,303,133 | 80.2 | 99.44 |
| HFD−G | 604,790,856 | 90,718,628,400 | 514,847,548 | 85.13 | 485,505,500 | 80.28 | 99.52 |
1 Bisulfite conversion rate = 1 − methylation rate of control DNA.
Number and proportion of methylated C bases in CON−G and HFD−G 1.
| CON−G | HFD−G | HFD−G VS CON−G | |||
|---|---|---|---|---|---|
| mC Number | Proportion (%) | mC Number | Proportion (%) | ΔmC/All ΔmC Proportion (%) | |
| mCG | 51,298,929 | 93.756 | 50,997,492 | 94.018 | 0.637 |
| mCHG | 903,726 | 1.652 | 859,466 | 1.584 | 0.094 |
| mCHH | 2,512,479 | 4.592 | 2,385,160 | 4.397 | 0.269 |
1 Methylated C (mC) screening method [41]. Binomial distribution test performed for methylated reads and non-methylated reads at C sites. The table shows the number and proportion of methylated reads greater than or equal to their expected value in the binomial distribution over a total effective coverage greater than or equal to 4.
Figure 1Distribution of mean methylation levels in functional areas of the gene region. This figure represented the methylation levels in the samples of CON-M and HFD-M groups. The entire gene was divided into seven different transcriptional elements in the X-axis. The length of each transcriptional element area was divided into an equal number of bin areas containing a certain number of bases. Each dot represented the mean methylation level of a bin region. The curve represented a five-point mean value of methylation level in each bin region. The vertical axis was the mean methylation level (values range from 0 to 1). The purple dotted line was the TSS position (Transcription start site). Different colored lines and dots represented different types of methylation levels between the two groups, respectively.
Number and length of differentially methylated regions (DMR) per chromosome in CON−G and HFD−G.
| chr1 | chr2 | chr3 | chr4 | chr5 | chr6 | chr7 | chr8 | chr9 | chr10 | |
| DMR number | 1331 | 1401 | 1051 | 776 | 335 | 496 | 617 | 742 | 1149 | 419 |
| DMR length | 396,041 | 421,303 | 305,229 | 218,887 | 96,186 | 132,605 | 187,769 | 219,937 | 331,992 | 125,477 |
| chr11 | chr12 | chr13 | chr14 | chr15 | chr16 | chr17 | chr18 | chr19 | chr20 | |
| DMR number | 509 | 892 | 1538 | 735 | 585 | 736 | 688 | 683 | 697 | 269 |
| DMR length | 154,160 | 265,709 | 426,667 | 221,132 | 178,538 | 214,250 | 194,860 | 196,669 | 194,099 | 74,580 |
| chr21 | chrX | Total | ||||||||
| DMR number | 264 | 476 | 5390 | |||||||
| DMR length | 71,604 | 156,157 | 1,570,251 |
Note: The number and length of DMR were the total numbers and total length of differential fragments in each chromosome.
Figure 2Enrichment analysis of genes methylated in the regions of promoter and gene body between CON−G and HFD−G. (a) KEGG enrichment analysis of genes in promoter and gene region, respectively. (b) Venn diagram of differential genes methylated in the regions of promoter and gene body from the two groups.
The key methylated genes were selected among the 288 skeletal muscle dual-methylated genes (promoter (P-DMR) and gene body (G-DMR) regions) in rabbits from the two groups.
| Description and Genes | Log2Ratio (HFD-M/CON-M) | Means-Gene Expression Levels | Log2FC (HFD-M/CON-M) | Up-Down-Regulation (HFD-M/CON-M) | ||
|---|---|---|---|---|---|---|
| P-DMR | G-DMR | CON-M | HFD-M | |||
| Solute carrier family 25 member 47 ( | 3.036 | 1.807 | 40.74781 | 41.64461 | 0.031407 | Up |
| Homeobox B5 ( | −2.907 | 1.034 | 7.40671 | 10.85412 | 0.551339 | Up |
| Late endosomal/lysosomal adaptor, MAPK, and MTOR activator 3 ( | −2.722 | −1.068 | 207.7547 | 228.8373 | 0.139441 | Up |
| Tetratricopeptide repeat domain 29 ( | −2.03 | −1.512 | 0.50368 | 0.511492 | 0.022204 | Up |
| Centromere protein H ( | −1.914 | −1.256 | 325.2772 | 354.271 | 0.123183 | Up |
| UTP18 small subunit processome component ( | 2.773 | 1.068 | 202.6769 | 175.4434 | −0.20818 | Down |
| PNMA family member 1 ( | 2.1 | 1 | 7.949022 | 7.626103 | −0.05983 | Down |
| Serpin family E member 1 ( | −2.138 | 1.034 | 313.767 | 182.1212 | −0.78479 | Down |
| Eukaryotic translation initiation factor 3 ( | −3.524 | 4.524 | 426.54 | 424.0606 | −0.00841 | Down |
| Intraflagellar transport 46 ( | −2 | −0.979 | 172.7577 | 170.0518 | −0.02278 | Down |
Figure 3Several different alternative splicing events and unique genes in skeletal muscle between the two groups. N1 and N2 represented the number of alternative splicing events identified in each category and the number of unique genes with such alternative splicing changes, respectively.
Enriched pathways associated with differentially alternative splicing genes in the skeletal muscle of CON−G and HFD−G rabbits.
| KEGG Pathway Terms | Fold Enrichment | Bonferroni | Benjamini | FDR | |
|---|---|---|---|---|---|
| ocu05410: Hypertrophic cardiomyopathy (HCM) | 4.3911 | 0.1647 | 0.1798 | 0.0009 | 0.1798 |
| ocu05414: Dilated cardiomyopathy | 3.6541 | 0.6843 | 0.5071 | 0.0059 | 0.5071 |
| ocu04510: Focal adhesion | 2.5133 | 0.7829 | 0.5071 | 0.0078 | 0.5071 |
| ocu04810: Regulation of the actin cytoskeleton | 2.2706 | 0.9872 | 1 | 0.0223 | 1 |
| ocu00563: Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 5.9221 | 0.9963 | 1 | 0.0286 | 1 |
| ocu03015: mRNA surveillance pathway | 2.9955 | 0.999935 | 1 | 0.0487 | 1 |
| ocu03040: Spliceosome | 2.3853 | 0.9999 | 1 | 0.0493 | 1 |
Figure 4The combined network construction and key genes analysis in skeletal muscle. (a) Venn diagram analysis of important genes with two modification modes. (b) Interaction network of key genes with exon-skipping alternative splicing and genes in differentially methylated regions (DMR) in skeletal muscle from CON−G and HFD−G rabbits. Hub genes were highly correlated genes within candidate modules.
Top 20 genes associated with high-fat content in skeletal muscle of rabbits.
| Description and Genes | Means-Gene | Log2FC | Up-Down-Regulation | Degree | Type | |
|---|---|---|---|---|---|---|
| CON-M | HFD-M | |||||
| UBX domain protein 7 ( | 395.9702 | 357.9715 | −0.14555 | Down | 28 | Hub |
| Titin ( | 6,762,662 | 6,303,461 | −0.10145 | Down | 22 | Hub |
| LIM domain binding 3 ( | 28,568.54 | 26,594.22 | −0.10331 | Down | 20 | Hub |
| Filamin C ( | 35,904.61 | 39,938.6 | 0.153615 | Up | 15 | Hub |
| Triadin ( | 9918.111 | 9663.512 | −0.03752 | Down | 15 | Hub |
| Adenosine monophosphate deaminase 1 ( | 17,171.82 | 14,074.44 | −0.28697 | Down | 13 | Hub |
| Protein kinase, DNA-activated, catalytic subunit ( | 531.1487 | 669.5437 | 0.334062 | Up | 13 | Hub |
| Muscleblind like splicing regulator 1 ( | 13,307.22 | 12,417.02 | −0.09989 | Down | 11 | Hub |
| Mitochondrial ribosomal protein S7 ( | 2238.874 | 2278.568 | 0.025354 | Up | 11 | Hub |
| Tropomyosin 2 ( | 33,609.41 | 60,754.3 | 0.854121 | Up | 11 | Hub |
| Troponin I1, slow skeletal type ( | 6160.928 | 9336.202 | 0.599688 | Up | 10 | Hub |
| Myosin binding protein C1 ( | 15,887.01 | 36,243.89 | 1.189891 | Up | 9 | Hub |
| Small muscle protein X-linked ( | 1575.926 | 3478.111 | 1.142104 | Up | 9 | Hub |
| Nebulin ( | 472,893.1 | 393,039.4 | −0.26684 | Down | 9 | Hub |
| Creatine kinase, M-type ( | 211,998.7 | 169,559.2 | −0.32227 | Down | 8 | Hub |
| TNF receptor-associated factor 3 ( | 232.8944 | 210.9551 | −0.14274 | Down | 8 | Hub |
| Myosin light polypeptide 6 ( | 2817.639 | 2572.484 | −0.13133 | Down | 7 | Hub |
| Mitochondrial ribosomal protein L35 ( | 341.1524 | 342.8565 | 0.007189 | Up | 5 | DMR |
| Ankyrin repeat domain 23 ( | 82,064.12 | 84,664.2 | 0.045 | Up | 5 | DMR |
| Solute carrier family 25 member 26 ( | 178.6897 | 198.0738 | 0.148582 | Up | 2 | DMR |
Degree was the number of nodes interacting with the selected node, and its size is related to the core degree of this node. Hub genes were highly correlated genes within candidate modules.